Lucius Capivasertib Tablet

Capivasertib functions as a selective inhibitor of the AKT signaling pathway, which is crucial for cell proliferation, survival, and metabolism. By targeting this pathway, LuciCapiva aims to inhibit tumor growth and induce cancer cell apoptosis (programmed cell death). This targeted action allows for a more precise treatment approach, potentially minimizing harm to surrounding healthy tissues.